According to the new market research report "Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer, IVD), End-User (Hospitals, Biotechnology) - Global Forecast to 2025" The global Cell Isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9 billion in 2020, at a 16.8% CAGR.
Browse and in-depth TOC on "Cell Isolation Market"
411 - Tables
38 - Figures
264 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479
The increasing government funding for cell-based research, the increasing number of patients suffering from cancer and infectious diseases, technological advancements, and the growing focus on personalized medicine are the major factors driving the cell isolation markets growth. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the cell isolation market.
The consumables segment accounted for the largest share of the cell isolation market, by product segment, in 2019
Based on product, the cell isolation market is segmented into consumables and instruments. In 2019, consumables segment accounted for the largest share. This can be attributed to the increasing investments by companies to develop technologically advanced products as well as the repetitive use of consumables.
Centrifugation- based segment accounted for the largest share of the cell isolation market, by technique segment, in 2019
Based on technique, the cell isolation market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. primarily due to the wide usage of this technique among end users. This technique is used on a large scale by biotech and biopharmaceutical companies as well as on a small scale by clinical research organizations and academia. The cost-effectiveness of this technique is another major reason for the large share of this segment. The growing demand for centrifugation techniques in biotech and biopharmaceutical companies is a major factor that is expected to drive the growth of this market segment in the coming years.
The biotechnology and biopharmaceutical companies segment accounted for the largest share in the market, by end user segment, in 2019
The cell isolation market is segmented into hospitals and diagnostic laboratories, biotechnology and biopharmaceutical companies, research laboratories and institutes, and other end users based on end users. In 2019, the biotechnology and biopharmaceutical companies segment accounted for the largest share. The widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies, as well as the increasing number of R&D facilities globally can be attributed for the the large share of this end-user segment.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479
North America is the largest regional market for cell isolation market
The cell isolation market is segmented into four regions, namely, North America, Europe, Asia Pacific and Rest of the world. In 2019, North America accounted for the largest share of the cell isolation market. The large share of North America can be attributed to technological advancements, growth in the biotechnology and pharmaceutical industries, increasing prevalence of chronic and infectious diseases, and higher investments in cell-based research in the region.
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company Limited (US), Beckman Coulter Inc. (US).Merck KGaA (Germany), Terumo BCT (Japan), GE Healthcare (US), Bio- Rad Laboratories Inc. (US), Corning Inc. (US), Roche Diagnostics (Switzerland, Alfa Laval (Sweden), Miltenyl Biotech (Germany), pluriSelect Life Science (Germany), STEMCELL Technologies Inc. (Canada), Akadeum Life Sciences, Inc (US), Bio- Techne (US), Bio Legend (US) and Invent Biotechnologies (US).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=103931479
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Email: [email protected]
Content Source: https://www.marketsandmarkets.com/PressReleases/cell-isolation.asp
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-isolation-market.asp